228 related articles for article (PubMed ID: 6082300)
21. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Mayo JG; Laster WR; Andrews CM; Schabel FM
Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
[No Abstract] [Full Text] [Related]
22. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
[No Abstract] [Full Text] [Related]
23. Combination therapy: some concepts and results.
Skipper HE
Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
[No Abstract] [Full Text] [Related]
24. Sesquiterpene lactones XVII. Cytostatic and pharmacological activity.
Hladoń B; Chodera A
Arch Immunol Ther Exp (Warsz); 1975; 23(6):857-65. PubMed ID: 1220638
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships: nitrosoureas.
Johnston TP
Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
[No Abstract] [Full Text] [Related]
26. Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.
Baldini L; Brambilla G; Cavanna M; Parodi S
Br J Pharmacol; 1968 Nov; 34(3):674P-676P. PubMed ID: 5726804
[No Abstract] [Full Text] [Related]
27. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
Thomson JM; Maruyama Y; Schwartz S; Hahn E
Radiology; 1971 Oct; 101(1):187-94. PubMed ID: 4329540
[No Abstract] [Full Text] [Related]
28. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
Hartmann NR; Dombernowsky P; Bichel P
Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
[No Abstract] [Full Text] [Related]
29. Peroral therapy with cytosine arabinoside. Preliminary laboratory and clinical findings.
Goldenberg DM; Schricker KT; von der Emde J; Sögtrop HH
Arzneimittelforschung; 1968 Jun; 18(6):712-4. PubMed ID: 5755808
[No Abstract] [Full Text] [Related]
30. Adoptive immunotherapy of acute leukemia: experimental and clinical results.
Mathé G; Amiel JL; Schwarzenberg L; Cattan A; Schneider M
Cancer Res; 1965 Oct; 25(9):1525-31. PubMed ID: 5323965
[No Abstract] [Full Text] [Related]
31. [Introduction of new screening system in National Cancer Institute].
Tsukagoshi S
Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
[No Abstract] [Full Text] [Related]
32. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
Kline I; Venditti JM; Tyrer DD; Goldin A
Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
[No Abstract] [Full Text] [Related]
33. [A strain of ascitic tumor NK-Ly, resistant to nitrosomethylurea].
Poroshenko GG; Gor'kova SN; Evseenko LS
Dokl Akad Nauk SSSR; 1968 Sep; 182(3):730-2. PubMed ID: 5737835
[No Abstract] [Full Text] [Related]
34. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
Mihich E; Mulhern AI
Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
[No Abstract] [Full Text] [Related]
35. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
Stoychkov JN; Miloushev AS
Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitivity of drug-resistant L1210 leukemia.
Johnson RE
Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
[No Abstract] [Full Text] [Related]
37. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
Rose WC; Trader MW; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
[No Abstract] [Full Text] [Related]
38. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Clifford P; Singh S; Stjernswärd J; Klein G
Cancer Res; 1967 Dec; 27(12):2578-615. PubMed ID: 6082297
[No Abstract] [Full Text] [Related]
40. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
Mihich E; Kitano M
Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
